1. A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R. (7th April 2021) Authors: Makimoto, Go; Ninomiya, Kiichiro; Kubo, Toshio; Sunami, Ryota; Kato, Yuka; Ichihara, Eiki; Ohashi, Kadoaki; Rai, Kammei; Hotta, Katsuyuki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura, Katsuyuki Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 6(2021) Page Start: 956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer. (December 2021) Authors: Yasuda, Hiroyuki; Ichihara, Eiki; Sakakibara-Konishi, Jun; Zenke, Yoshitaka; Takeuchi, Shinji; Morise, Masahiro; Hotta, Katsuyuki; Sato, Mineyoshi; Matsumoto, Shingo; Tanimoto, Azusa; Matsuzawa, Reiko; Kiura, Katuyuki; Takashima, Yuta; Yano, Seiji; Koyama, Junji; Fukushima, Takahiro; Hamamoto, Ju... Journal: Lung cancer Issue: Volume 162(2021) Page Start: 140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202. (October 2017) Authors: Kuyama, Shoichi; Ochi, Nobuaki; Bessho, Akihiro; Hotta, Katsuyuki; Ikeda, Genyo; Kishino, Daizo; Kubo, Toshio; Harada, Daijiro; Fujimoto, Nobukazu; Nakanishi, Masamoto; Umeno, Takahiro; Okada, Toshiaki; Chikamori, Kenichi; Yamagishi, Tomoko; Ohashi, Kadoaki; Ichihara, Eiki; Takigawa, Nagio; Tanim... Journal: Lung cancer Issue: Volume 112(2017) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients with Non–Small-Cell Lung Cancer. Issue 8 (August 2015) Authors: Ichihara, Eiki; Hotta, Katsuyuki; Kiura, Katsuyuki Journal: Journal of thoracic oncology Issue: Volume 10:Issue 8(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS1 fusions. Issue 10 (11th September 2018) Authors: Kato, Yuka; Ninomiya, Kiichiro; Ohashi, Kadoaki; Tomida, Shuta; Makimoto, Go; Watanabe, Hiromi; Kudo, Kenichiro; Matsumoto, Shingo; Umemura, Shigeki; Goto, Koichi; Ichihara, Eiki; Ninomiya, Takashi; Kubo, Toshio; Sato, Akiko; Hotta, Katsuyuki; Tabata, Masahiro; Toyooka, Shinichi; Maeda, Yoshinobu... Journal: Cancer science Issue: Volume 109:Issue 10(2018) Page Start: 3149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Erratum to: Impact of previous thoracic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer. (2nd July 2021) Authors: Hosokawa, Shinobu; Ichihara, Eiki; Bessho, Akihiro; Harada, Daijiro; Inoue, Koji; Shibayama, Takuo; Kishino, Daizo; Harita, Shingo; Ochi, Nobuaki; Oda, Naohiro; Hara, Naofumi; Hotta, Katsuyuki; Maeda, Yoshinobu; Kiura, Katsuyuki Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 8(2021) Page Start: 1348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients. (1st September 2020) Authors: Kubo, Toshio; Watanabe, Hiromi; Ninomiya, Kiichiro; Kudo, Kenichiro; Minami, Daisuke; Murakami, Etsuko; Ochi, Nobuaki; Ninomiya, Takashi; Harada, Daijiro; Yasugi, Masayuki; Ichihara, Eiki; Ohashi, Kadoaki; Rai, Kammei; Fujiwara, Keiichi; Hotta, Katsuyuki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura... Journal: Japanese journal of clinical oncology Issue: Volume 50:Number 12(2020) Page Start: 1447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of previous thoracic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non small cell lung cancer. (14th October 2020) Authors: Hosokawa, Shinobu; Ichihara, Eiki; Bessho, Akihiro; Harada, Daijiro; Inoue, Koji; Shibayama, Takuo; Kishino, Daizo; Harita, Shingo; Ochi, Nobuaki; Oda, Naohiro; Hara, Naofumi; Hotta, Katsuyuki; Maeda, Yoshinobu; Kiura, Katsuyuki Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 2(2021) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancer. (14th October 2020) Authors: Hosokawa, Shinobu; Ichihara, Eiki; Bessho, Akihiro; Harada, Daijiro; Inoue, Koji; Shibayama, Takuo; Kishino, Daizo; Harita, Shingo; Ochi, Nobuaki; Oda, Naohiro; Hara, Naofumi; Hotta, Katsuyuki; Maeda, Yoshinobu; Kiura, Katsuyuki Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 2(2021) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis. (3rd March 2020) Authors: Ninomiya, Kiichiro; Oze, Isao; Kato, Yuka; Kubo, Toshio; Ichihara, Eiki; Rai, Kammei; Ohashi, Kadoaki; Kozuki, Toshiyuki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura, Katsuyuki; Hotta, Katsuyuki Journal: Acta oncologica Issue: Volume 59:Number 3(2020) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗